Cargando…
Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies
INTRODUCTION: Burdensome symptoms of atopic dermatitis include itch and sleep disturbance. This post hoc analysis reports the effect of baricitinib on itch and sleep disturbance during the first week of treatment in 3 phase 3 studies. METHODS: Patients were randomized 2:1:1:1 to once-daily placebo o...
Autores principales: | Buhl, Timo, Rosmarin, David, Serra-Baldrich, Esther, Fernandez-Peñas, Pablo, Igarashi, Atsuyuki, Konstantinou, Maria Polina, Chen, Sherry, Lu, Na, Pierce, Evangeline, Casillas, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163921/ https://www.ncbi.nlm.nih.gov/pubmed/33899152 http://dx.doi.org/10.1007/s13555-021-00534-8 |
Ejemplares similares
-
The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials
por: Yosipovitch, Gil, et al.
Publicado: (2022) -
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7
por: Thyssen, Jacob P., et al.
Publicado: (2021) -
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
por: de Bruin-Weller, Marjolein S., et al.
Publicado: (2022) -
How to measure itch in atopic dermatitis?
por: Oosterhaven, J.A.F.
Publicado: (2020) -
Itch in Atopic Dermatitis – What Is New?
por: Legat, Franz J.
Publicado: (2021)